
The latest announcement is out from Cardlytics ( ($CDLX) ). On November 16, 2026, Cardlytics announced a plan to reduce its workforce by approximately 30 full-time employees, or about 15%
Compare up to 40 stocks
Compared Stocks: 1 / 40
| Ticker | Company Name | Price | Change | % Change | |
|---|---|---|---|---|---|
| CDLX | Cardlytics | 1.11 | -8.81 | -88.81% |
| Name | Price | % Change | |
|---|---|---|---|
| $1.11 | -88.81% |

The latest announcement is out from Cardlytics ( ($CDLX) ). On November 16, 2026, Cardlytics announced a plan to reduce its workforce by approximately 30 full-time employees, or about 15%

Cardlytics, Inc. (($CDLX)) has held its Q3 earnings call. Read on for the main highlights of the call. Cardlytics’ earnings call presented a mixed picture, with weak third-quarter results offset

BofA lowered the firm’s price target on Cardlytics (CDLX) to $1.70 from $4 and keeps an Underperform rating on the shares. The company’s Q3 came in below guidance on the

Craig-Hallum analyst Jason Kreyer lowered the firm’s price target on Cardlytics (CDLX) to $4 from $6 and keeps a Hold rating on the shares after a mixed Q3 as revenue

Lake Street lowered the firm’s price target on Cardlytics (CDLX) to $2 from $4 and keeps a Hold rating on the shares after Q3 results fell short of expectations. Published

Reports Q3 revenue $32.9M, consensus $37.07M. “Our third quarter results came in below expectations,” said Amit Gupta, CEO of Cardlytics (CDLX). “However, we remain encouraged by the progress towards our

Sees Q4 adjusted EBITDA ($1M)-$2M Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See Insiders’ Hot Stocks on TipRanks >> Read More

Cardlytics (CDLX) announced a new partnership with Rove extending the Cardlytics Rewards Platform and further diversifying Cardlytics’ supply footprint. The partnership gives Rove members access to Cardlytics’ full offers program,

Cardlytics ( ($CDLX) ) has provided an announcement. Cardlytics has disclosed the resolution of a legal dispute stemming from indemnification obligations it assumed in its 2021 acquisition of Bridg, Inc.,

Cardlytics, Inc. (($CDLX)) has held its Q2 earnings call. Read on for the main highlights of the call. Cardlytics’ latest earnings call struck a cautious but constructive tone, as management
| Name | Upcoming Earnings Date | Market Cap | EPS Forecast | Sales Forecast | PEG Ratio | P/E Ratio |
|---|---|---|---|---|---|---|
| Mar 2, 2027TBA | $7.44M | $-1.49 | $35.54M | 0.01 | -0.19 |
Compare Stocks Side-by-Side
Our stock comparison tool allows investors to compare multiple stocks simultaneously, providing comprehensive insights into key metrics, financial data, and analyst ratings. Make informed investment decisions by analyzing stocks side by side.
Key Features of Our Stock Comparison
How to Use the Stock Comparison Tool
Simply enter the ticker symbols of the stocks you want to compare in the search box above. You can add up to 40 stocks at once. The tool will automatically populate comparison tables with the latest data, allowing you to analyze and contrast different investment opportunities across various sectors and industries.
Popular Stock Comparisons
Investors frequently compare stocks within the same sector to identify the best investment opportunities. Popular comparisons include tech giants like Apple (AAPL) vs. Microsoft (MSFT), semiconductor leaders Nvidia (NVDA) vs. AMD, beverage companies Coca-Cola (KO) vs. Pepsi (PEP), and electric vehicle makers Tesla (TSLA) vs. Rivian (RIVN).
Why Compare Stocks?
Comparing stocks helps investors identify which companies offer the best value, growth potential, and risk-adjusted returns. By analyzing multiple stocks side by side, you can better understand relative valuations, competitive advantages, and market positioning before making investment decisions.